WallStreetZenWallStreetZen

NASDAQ: GLPG
Galapagos Nv Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their GLPG stock forecasts and price targets.

Forecast return on equity

Is GLPG forecast to generate an efficient return?

Company
-1.25%
Industry
126.43%
Market
-47.44%
GLPG's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is GLPG forecast to generate an efficient return on assets?

Company
-0.87%
Industry
47.5%
GLPG is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

GLPG earnings per share forecast

What is GLPG's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$4.90
Avg 2 year Forecast
-$1.20
Avg 3 year Forecast
-$1.11

GLPG revenue forecast

What is GLPG's revenue in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
$258.8M
Avg 2 year Forecast
$243.0M
Avg 3 year Forecast
$317.4M

GLPG vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GLPG$32.91N/AN/A
IDYA$24.75$48.67+96.63%Strong Buy
DNLI$14.82$32.14+116.89%Strong Buy
AGIO$37.45$61.50+64.22%Buy
CELC$51.57$56.50+9.56%Strong Buy
View Top Biotech Stocks

Galapagos Nv Stock Forecast FAQ

What is GLPG's earnings growth forecast for 2025-2027?

(NASDAQ: GLPG) Galapagos Nv's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.24%.

Galapagos Nv's earnings in 2025 is N/A.On average, 5 Wall Street analysts forecast GLPG's earnings for 2025 to be -$322,763,854, with the lowest GLPG earnings forecast at -$410,538,752, and the highest GLPG earnings forecast at -$136,406,937. On average, 5 Wall Street analysts forecast GLPG's earnings for 2026 to be -$78,944,691, with the lowest GLPG earnings forecast at -$240,524,309, and the highest GLPG earnings forecast at $38,879,272.

In 2027, GLPG is forecast to generate -$72,816,263 in earnings, with the lowest earnings forecast at -$119,273,699 and the highest earnings forecast at -$26,358,828.

If you're new to stock investing, here's how to buy Galapagos Nv stock.

What is GLPG's revenue growth forecast for 2025-2027?

(NASDAQ: GLPG) Galapagos Nv's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.68%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.94%.

Galapagos Nv's revenue in 2025 is N/A.On average, 3 Wall Street analysts forecast GLPG's revenue for 2025 to be $17,053,041,725, with the lowest GLPG revenue forecast at $5,151,174,040, and the highest GLPG revenue forecast at $23,670,227,903. On average, 3 Wall Street analysts forecast GLPG's revenue for 2026 to be $16,011,868,003, with the lowest GLPG revenue forecast at $5,161,058,601, and the highest GLPG revenue forecast at $21,886,394,191.

In 2027, GLPG is forecast to generate $20,917,048,277 in revenue, with the lowest revenue forecast at $20,646,211,315 and the highest revenue forecast at $21,187,885,239.

What is GLPG's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: GLPG) forecast ROA is -0.87%, which is lower than the forecast US Biotechnology industry average of 47.5%.

What is GLPG's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: GLPG) Galapagos Nv's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that GLPG's EPS will be -$4.90 for 2025, with the lowest EPS forecast at -$6.23, and the highest EPS forecast at -$2.07. On average, analysts forecast that GLPG's EPS will be -$1.20 for 2026, with the lowest EPS forecast at -$3.65, and the highest EPS forecast at $0.59. In 2027, GLPG's EPS is forecast to hit -$1.11 (min: -$1.81, max: -$0.40).

What is GLPG's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: GLPG) forecast ROE is -1.25%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.